Document is current
Any future updates will be listed below
-
Authors
Gupta, Kiran
Trocio, Jeffrey
Keshishian, Allison https://orcid.org/0000-0002-9986-1227
Zhang, Qisu
Dina, Oluwaseyi
Mardekian, Jack
Nadkarni, Anagha
Shank, Thomas C
-
Funding
Funding for this research was provided by:
Pfizer (n/a)
Bristol-Myers Squibb (n/a)
- License Information
-
More Information
Article History
Received: 7 January 2019
Accepted: 22 May 2019
First Online: 13 June 2019
Ethics approval and consent to participate
: This retrospective database analysis did not involve the collection, use, or transmittal of individual identifiable data. As such, Institutional Review Board (IRB) approval to conduct this study was not required and considered exempt according to 45CFR46.101(b)(4): Existing Data & Specimens - No Identifiers. Both the data set itself and the security of the offices where the data are housed meet the requirements of the Health Insurance Portability and Accountability Act (HIPAA) of 1996.
: Since this retrospective database analysis did not involve the collection, use, or transmittal of individual identifiable data, patient consent was not required.
: Gupta and Nadkarni are employees of Bristol-Myers Squibb Company, with ownership of stocks in Bristol-Myers Squibb Company. Trocio, Dina, Mardekian, and Shank are employees of Pfizer Inc., with ownership of stocks in Pfizer Inc. Keshishian and Zhang are employees of STATinMED Research, a paid consultant to Pfizer and Bristol-Myers Squibb in connection with this study and the development of this manuscript.
